Join to view full profile
251 E Huron StChicago, IL 60611
Phone+1 312-926-2000
Dr. Marinelarena is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Illinois College of MedicineClass of 2017
Certifications & Licensure
IL State Medical License 2020 - 2029
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Resistance to the KRASG12D Inhibitor MRTX1133 Is Associated with Increased Sensitivity to BET Inhibition.Daniel R Principe, Jeffrey H Becker, Anastasia E Metropulos, Alejandra M Marinelarena, Thao D Pham
Molecular Cancer Therapeutics. 2026-06-01 - 3 citationsResistance to the KRASInhibitor MRTX1133 is Associated with Increased Sensitivity to BET Inhibition.Daniel R Principe, Jeffrey H Becker, Anastasia E Metropulos, Alejandra M Marinelarena, Thao D Pham
Biorxiv. 2025-05-13 - 8 citationsTargeting BCL2 with Venetoclax Enhances the Efficacy of the KRASG12D Inhibitor MRTX1133 in Pancreatic Cancer.Jeffrey H Becker, Anastasia E Metropulos, Christina Spaulding, Alejandra M Marinelarena, Mario A Shields
Cancer Research. 2024-11-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
